Skip to main content

Table 3 Effect of YGMM on T-SOD, GSH, and MDA levels in alcoholic liver injury of rats

From: Evaluation of the hepatoprotective effect of Yigan mingmu oral liquid against acute alcohol-induced liver injury in rats

Group Liver Kidney
  T-SOD
(U/mg protein)
GSH
(mg/g protein)
MDA
(nmol/mg protein)
T-SOD
(U/mg protein)
GSH
(mg/g protein)
MDA
(nmol/mg protein)
Control 214.67 ± 22.34 3.32 ± 0.37 1.53 ± 0.20 127.90 ± 15.81 3.95 ± 0.19 0.88 ± 0.04
Alcohol 180.71 ± 5.71 2.43 ± 0.24# 1.57 ± 0.11 99.43 ± 4.17 3.39 ± 0.11# 0.77 ± 0.04
Silymarin 199.52 ± 6.48 2.91 ± 0.11 1.57 ± 0.16 86.15 ± 3.30 3.03 ± 0.14 1.22 ± 0.07***
YGMM (low dose) 220.10 ± 18.50 3.18 ± 0.23* 1.61 ± 0.13 100.47 ± 14.39 3.72 ± 0.16 0.86 ± 0.06
YGMM (medium dose) 209.49 ± 8.93 2.86 ± 0.22 1.70 ± 0.24 85.07 ± 3.31 3.05 ± 0.19 0.73 ± 0.08
YGMM (high dose) 210.86 ± 19.61 2.96 ± 0.03 1.83 ± 0.13 96.94 ± 4.12 3.42 ± 0.15 0.47 ± 0.10**
  1. Data are presented as mean ± SEM in each group. #p < 0.05 compared with the normal control group; *p < 0.05, **p < 0.01, ***p < 0.001 compared with the alcohol group